Welcome guest, Login | Register


David Balayssac


PhD in Toxicology, Faculté de Pharmacie, Université d’Auvergne, Clermont-Ferrand, France, 2005

Current position

Associate Professor and Hospital practitioner, Laboratoire de Toxicologie, Université d’Auvergne, Clermont-Ferrand, France

Publications (since 2005)

  1. Balayssac, D., Pereira, B., Bazin, J. E., Le Roy, B., Pezet, D. and Gagniere, J. (2016). Warmed and humidified carbon dioxide for abdominal laparoscopic surgery: meta-analysis of the current literature. Surg Endosc.

  2. Le Roy, B., Tixier, L., Pereira, B., Sauvanet, P., Buc, E., Petorin, C., Dechelotte, P., Pezet, D. and Balayssac, D. (2016). Assessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control Study. PLoS One 11(2): e0148739.

  3. Ferrier, J., Bayet-Robert, M., Dalmann, R., El Guerrab, A., Aissouni, Y., Graveron-Demilly, D., Chalus, M., Pinguet, J., Eschalier, A., Richard, D., Daulhac, L., Marchand, F. and Balayssac, D. (2015). Cholinergic Neurotransmission in the Posterior Insular Cortex Is Altered in Preclinical Models of Neuropathic Pain: Key Role of Muscarinic M2 Receptors in Donepezil-Induced Antinociception. J Neurosci 35(50): 16418-16430.

  4. Dubois, A., Carrier, G., Pereira, B., Gillet, B., Faucheron, J. L., Pezet, D. and Balayssac, D. (2015). Therapeutic management of complex anal fistulas by installing a nitinol closure clip: study protocol of a multicentric randomised controlled trial--FISCLOSE. BMJ Open 5(12): e009884.

  5. Poupon, L., Kerckhove, N., Vein, J., Lamoine, S., Authier, N., Busserolles, J. and Balayssac, D. (2015). Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives. Expert Opin Drug Saf 14(8): 1269-1282.

  6. Paul, C., Zenut, M., Dorut, A., Coudore, M. A., Vein, J., Cardot, J. M. and Balayssac, D. (2015). Response to "Use of domperidone to increase breast milk supply: further consideration of the benefit-risk ratio is required". J Hum Lact 31(2): 316-317.

  7. Balayssac, D., Ferrier, J., Pereira, B., Gillet, B., Petorin, C., Vein, J., Libert, F., Eschalier, A. and Pezet, D. (2015). Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet-NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial. BMJ Open 5(4): e007479.

  8. Paul, C., Zenut, M., Dorut, A., Coudore, M. A., Vein, J., Cardot, J. M. and Balayssac, D. (2015). Use of domperidone as a galactagogue drug: a systematic review of the benefit-risk ratio. J Hum Lact 31(1): 57-63.

  9. Balayssac, D., Ling, B., Ferrier, J., Pereira, B., Eschalier, A. and Authier, N. (2014). Assessment of thermal sensitivity in rats using the thermal place preference test: description and application in the study of oxaliplatin-induced acute thermal hypersensitivity and inflammatory pain models. Behav Pharmacol 25(2): 99-111.

  10. Ferrier, J., Bayet-Robert, M., Pereira, B., Daulhac, L., Eschalier, A., Pezet, D., Moulinoux, J. P. and Balayssac, D. (2013). A polyamine-deficient diet prevents oxaliplatin-induced acute cold and mechanical hypersensitivity in rats. PLoS One 8(10): e77828.

  11. Ferrier, J., Pereira, V., Busserolles, J., Authier, N. and Balayssac, D. (2013). Emerging trends in understanding chemotherapy-induced peripheral neuropathy. Curr Pain Headache Rep 17(10): 364.

  12. Balayssac, D., Poinas, A. C., Pereira, B. and Pezet, D. (2013). Use of permacol in parietal and general surgery: a bibliographic review. Surg Innov 20(2): 176-182.

  13. Balayssac, D., Ferrier, J., Descoeur, J., Ling, B., Pezet, D., Eschalier, A. and Authier, N. (2011). Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence. Expert Opin Drug Saf 10(3): 407-417.

  14. Authier, N., Balayssac, D., Sautereau, M., Zangarelli, A., Courty, P., Somogyi, A. A., Vennat, B., Llorca, P. M. and Eschalier, A. (2009). Benzodiazepine dependence: focus on withdrawal syndrome. Ann Pharm Fr 67(6): 408-413.

  15. Authier, N., Balayssac, D., Marchand, F., Ling, B., Zangarelli, A., Descoeur, J., Coudore, F., Bourinet, E. and Eschalier, A. (2009). Animal models of chemotherapy-evoked painful peripheral neuropathies. Neurotherapeutics 6(4): 620-629.

  16. Balayssac, D., Cayre, A., Ling, B., Maublant, J., Penault-Llorca, F., Eschalier, A., Coudore, F. and Authier, N. (2009). Increase in morphine antinociceptive activity by a P-glycoprotein inhibitor in cisplatin-induced neuropathy. Neurosci Lett 465(1): 108-112.

  17. Balayssac, D., Cayre, A., Ling, B., Maublant, J., Penault-Llorca, F., Eschalier, A., Coudore, F. and Authier, N. (2008). Vincristine-induced neuropathy in the rat is not modified by drug-drug interactions with the P-glycoprotein inhibitor verapamil. Chemotherapy 54(5): 336-342.

  18. Balayssac, D., Zangarelli, A. and Authier, N. (2008). Association of cannabis smoking and periodontal disease. JAMA 299(19): 2273; author reply 2273-2274.

  19. Ling, B., Coudore-Civiale, M. A., Balayssac, D., Eschalier, A., Coudore, F. and Authier, N. (2007). Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat. Toxicology 234(3): 176-184.

  20. Ling, B., Authier, N., Balayssac, D., Eschalier, A. and Coudore, F. (2007). Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat. Pain 128(3): 225-234.

  21. Balayssac, D., Cayre, A., Authier, N., Ling, B., Maublant, J., Eschalier, A., Penault-Llorca, F. and Coudore, F. (2006). Involvement of the multidrug resistance transporters in cisplatin-induced neuropathy in rats. Comparison with the chronic constriction injury model and monoarthritic rats. Eur J Pharmacol 544(1-3): 49-57.

  22. Ling, B., Authier, N., Balayssac, D., Eschalier, A. and Coudore, F. (2005). Assessment of nociception in acrylamide-induced neuropathy in rats. Pain 119(1-3): 104-112.

  23. Balayssac, D., Cayre, A., Authier, N., Bourdu, S., Penault-Llorca, F., Gillet, J. P., Maublant, J., Eschalier, A. and Coudore, F. (2005). Patterns of P-glycoprotein activity in the nervous system during vincristine-induced neuropathy in rats. J Peripher Nerv Syst 10(3): 301-310.

  24. Balayssac, D., Authier, N., Cayre, A. and Coudore, F. (2005). Does inhibition of P-glycoprotein lead to drug-drug interactions? Toxicol Lett 156(3): 319-329.

Protocols by David Balayssac
  1. Assessment of Mechanical Allodynia in Rats Using the Electronic Von Frey Test